Shared early autoantibody recognition events in the development of anti- Sm B/B' in human lupus

Scandinavian Journal of Immunology

Volumn 50, Issue 5, 1999, Pages 447-455

  Arbuckle, M R ^a,b   Reichlin, M ^a,b   Harley, J B ^c   James, Judith A ^a,b  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CROSS REACTING ANTIBODY; EPITOPE;

AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOASSAY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

AMINO ACID SEQUENCE; AUTOANTIBODIES; AUTOANTIGENS; BINDING SITES; CROSS REACTIONS; EPITOPE MAPPING; EPITOPES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RIBONUCLEOPROTEINS, SMALL NUCLEAR; TIME FACTORS;

EID: 0032695519     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1999.00640.x     Document Type: Article

References (39)

1. Perry LL, Barzaga ME. Kinetics and specificity of T and B cell responses in relapsing experimental allergic encephalomyelitis. J Immunol 1987;138:1434-41.
2. Lehmann PV, Forsthuber T, Miller A, Sercarz EE. Spreading of T cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992;359:155-7.
3. McRae BL, Vanderlugt CL, Dal Canto MC, Miller SD. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J Exp Med 1995;182:75-85.
4. Miller SD, McRae BL, Vanderlugt CL et al. Evolution of the T cell repertoire during the course of experimental immune-mediated demyelinating diseases. Immunol Rev 1995;144:224-44.
5. Yu MJ, Johnson M, Tuohy VK. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: A basis for peptide specific therapy after onset of clinical disease. J Exp Med 1996;183:1777-88.
6. James JA, Gross T, Scofield RH, Harley JB. Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B′-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity. J Exp Med 1995;181:453-61.
7. Scofield RH, Henry WE, Kurien BT, James JA, Harley JB. Immunization with short peptides derived from the systemic lupus erythematosus associated 60 kD Ro autoantigen results in anti-Ro ribonucleoprotein autoimmunity. J Immunol 1998;156:41159-66.
8. Harley JB, James JA. A model of peptide-induced lupus auto-immune B cell epitope spreading is strain specific and is not H-2 restricted in mice. J Immunol 1998;160:502-8.
9. Topfer F, Gordon T, McCluskey J. Intra- and inter-molecular spreading of autoimmunity involving the nuclear self-antigens La (SS-B) and Ro (SS-A). Proc Nat Acad Sci USA 1995:92:875-9.
10. Keech, CL, Gordon TP, McCluskey J. The immune response to 52-kDa and 60 kDa Ro is linked in experimental autoimmunity. J Immunol 1996;157:3694-9.
11. Kaufman DL, Clare-Salzler M, Tian J et al. Spontaneous loss of T cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993;366:69-72.
12. Tisch R, Yang X-Z, Singer SM, Liblau RS. Fugger L, McDevitt HO. Immune response to insulitis in non-obese diabetic mice. Nature 1993;366:72-5.
13. Rhim SH, Miller SE, Robey F et al. Autoimmune disease of the ovary induced by a ZP3 peptide from the mouse zona pellucida. J Clin Invest 1992;89:28-35.
14. Garza KM, Tung KSK. Frequency of molecular mimicry among T cell peptides as the basis for autoimmune disease and autoantibody induction. J Immunol 1995;155:5444-8.
15. Reichlin M, Friday K, Harley JB. Complete congenital heart block followed by the development of antibodies to Ro/SSA in adult life: Serological, clinical and HLA studies in and informative family. Am J Med 1988;84:339-44.
16. Aho K, Koskela P, Makitalo R, Heliovaara M, Palosuo T. Anti-nuclear antibodies hearalding the onset of systemic lupus erythematosus. J Rheumatol 1992;19:1377-9.
17. Stafford HA, Anderson CJ, Blalock DB, Reichlin M. Development of the anti-ribosomal P autoantibody response. Clin Exp Rheum 1998;16:119-24.
18. Scofield RH, Zhang F, Kurien BT et al. Development of the anti-Ro autoantibody response in a patient with systemic lupus erythematosus. Arthritis Rheum 1996;39:1664-8.
19. Satoh M, Hamilton KJ, Langdon JJ et al. Late development of anti-La/SS-B antibodies in a patient with Sjögren's syndrome and high liter anti-Ro/SS-A antibodies. Lupus 1996;5:337-9.
20. Tan EM et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
21. Maddison PJ, Reichlin M. Quantitation of precipitating antibodies to certain soluble nuclear antigens in systemic lupus erythematosus. Their contribution to hyperglobulinemia. Arthritis Rheum 1977;20:819-24.
22. Gonzalez EN, Rothfield NF. Immunoglobulin class and pattern of nuclear fluorescence in systemic lupus erythematosus. N Engl J Med 1966;271:1333-8.
23. Arden A, de Groot ER, Fletkamp TEW. Immunology of DNA. III. Crithidia luciliac, a simple substrate for the determination of anti-dsDNA with the immunofluorescnce technique. Ann NY Acad Sci 1975;254:505-15.
24. James JA et al. Antigenicity of a recombinant Ro (SS-A) fusion protein. Arthritis Rheum 1990;33:102-6.
25. James JA, Harley JB. Linear epitope mapping of an Sm B/B′ protein. J Immunol 1992;148:2074-9.
26. James JA, Mamula M, Harley JB. Sequential autoantigenic determinants of the small nuclear ribonucleoprotein Sm D are shared by human lupus autoantibodies and MRL Ipr/Ipr antibodies. Clin Exp Immunol 1994;98:419-26.
27. Axen R, Porath J, Ernback S. Chemical coupling of peptides and proteins to polysaccharides by means of cyanogen halides. Nature 1967;214:1302-5.
28. Kohn J, Wilcheck M. The use of cyanogen bromide and other novel cyanylating agents for the activation of polysaccharide resins. Appl Biochem Biotechnol 1984;9:285-304.
29. Naserke HE, Ziegler AG, Lampasona V, Bonifacio E. Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type I diabetes. J Immunol 1998;161:6963-9.
30. Roll UMR, Christie M, Fuchtenbusch M, Payton MA, Hawkes CJ, Ziegler AG, Perinatal autoimmunity in of offspring of diabetic parents. The German multicenter BABY-DIAB study. Diabetes 1996;45:967-73.
31. Tuohy VK, Yu M, Weinstock-Guttman B, Kinkel RP. Diversity and plasticity of self recognition during the development of multiple sclerosis. J Clin Invest 1997;99:1682-90.
32. James JA, Harley JB. B cell epitope spreading in autoimmunity. Immunol Rev 1998;164:184-200.
33. Howard W, Watts C. Epitope-directed processing of specific antigen by B Lymphocytes. J Cell Biology 1989;109:85-92.
34. Arbuckle MR, Schilling AR, Harley JB, James JA. A limited lupus anti-spliceosomal response targets a cross-reactive, proline rich motif. J Autoimmunity 1998;11:1-8.
35. James JA, McClain MT, Koelsch G, Williams DG, Harley JB. Side chain specificities and molecular modeling of peptide determinants for two anti-Sm B/B′ autoantibodies. J Autoimmun 1998;11:203-7.
36. Tsikaris V, Vlachoyiannopoulos PG, Panos Pomonis E et al. Immuno-reactivity and conformation of the P-P-G-M-R-P-P repetitive epitope of the Sm autoantigen. Int J Peptide Protein Res 1996;48;319-27.
37. Petrovas CJ, Vlachoyiannopoulos PG, Tzioufas AG et al. A major Sm epitope anchored to sequential oligopeptide carriers is a suitable antigenic substrate to detect anti-Sm antibodies. J Immunol Methods 1998;220:59-68.
38. James JA, Scofield RH, Harley JB. Lupus autoimmunity after short peptide immunization. Ann NY Acad Sci 1997;815:124-7.
39. James JA, Kauhnan KM, Farris AD, Taylor-Albert E, Lehman TJA, Harley JB. An increased prevalence of Epslein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest 1997;100:3019-26.